| scholarly article | Q13442814 |
| P2093 | author name string | David Alexoff | |
| Bruce M Cohen | |||
| Jacob M Hooker | |||
| Cécile Béguin | |||
| Youwen Xu | |||
| Colleen Shea | |||
| Thomas A Munro | |||
| P2860 | cites work | Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist | Q24535736 |
| 2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A | Q24642017 | ||
| Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers | Q24651427 | ||
| Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist | Q24656126 | ||
| Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses | Q24683322 | ||
| Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats | Q28273954 | ||
| Possible pharmacotherapy of the opioid kappa receptor agonist for drug dependence | Q28293155 | ||
| Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats | Q28307145 | ||
| Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal | Q28379331 | ||
| Salvinorin A analogs as probes in opioid pharmacology | Q30439719 | ||
| Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors | Q33984723 | ||
| Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. | Q34165326 | ||
| Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats | Q34185186 | ||
| A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A. | Q34350014 | ||
| Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats | Q34459404 | ||
| Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18). | Q34538561 | ||
| Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats | Q34682154 | ||
| 8-epi-Salvinorin B: crystal structure and affinity at the kappa opioid receptor | Q35652097 | ||
| Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans. | Q36766665 | ||
| Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum | Q36979184 | ||
| Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid | Q37192749 | ||
| Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen | Q37286215 | ||
| Natural products as tools for neuroscience: discovery and development of novel agents to treat drug abuse | Q37355904 | ||
| Pharmacological mechanisms of opioid analgesics. | Q39496101 | ||
| Sensitization to the Behavioral Effects of Cocaine: Modulation by Dynorphin and κ-Opioid Receptor Agonists | Q41527783 | ||
| Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse | Q44350970 | ||
| In vitro stability and metabolism of salvinorin A in rat plasma | Q46091354 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 386-391 | |
| P577 | publication date | 2009-07-08 | |
| P1433 | published in | Neuropharmacology | Q15332439 |
| P1476 | title | Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residence | |
| P478 | volume | 57 |
| Q35637848 | A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior. |
| Q88257901 | A review of salvinorin analogs and their kappa-opioid receptor activity |
| Q46178251 | Analysis of Salvinorin A in urine using microextraction in packed syringe and GC-MS/MS. |
| Q58611571 | Chemogenetic inactivation of the dorsal hippocampus and medial prefrontal cortex, individually and concurrently, impairs object recognition and spatial memory consolidation in female mice |
| Q38902043 | Clerodane diterpenes: sources, structures, and biological activities |
| Q64111902 | Cutting-Edge Search for Safer Opioid Pain Relief: Retrospective Review of Salvinorin A and Its Analogs |
| Q30447153 | Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans |
| Q36894509 | Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET. |
| Q37725698 | Kappa opioids and the modulation of pain |
| Q37451366 | LC-MS/MS quantification of salvinorin A from biological fluids |
| Q30467220 | Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A |
| Q34851195 | Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin A. |
| Q57888900 | Salvia divinorum: toxicological aspects and analysis in human biological specimens |
| Q34820974 | Salvinorin A decreases mortality and improves neurological outcome in a neonatal mouse hypoxia model |
| Q42073472 | Salvinorin B methoxymethyl ether |
| Q36775253 | Selective Manipulation of Neural Circuits |
| Q37495486 | Studies toward bivalent κ opioids derived from salvinorin A: heteromethylation of the furan ring reduces affinity. |
| Q47878237 | The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects. |
| Q33835281 | The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects |
Search more.